1. Gan TJ. Poorly controlled postoperative pain: Prevalence, consequences, and prevention. J Pain Res. 2017;10:2287–98.
2. Mwaka G, Thikra S, Mung’ayi V. The prevalence of postoperative pain in the first 48 hours following day surgery at a tertiary hospital in Nairobi. Afr Health Sci. 2013;13(3):768–76.
3. Johansen A, Romundstad L, Nielsen CS, Schirmer H, Stubhaug A. Persistent postsurgical pain in a general population: Prevalence and predictors in the Tromsø study. Pain [Internet]. 2012;153(7):1390–6. Available from: http://dx.doi.org/10.1016/j.pain.2012.02.018
4. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367(9522):1618–25.
5. Wu CL, Raja SN. Treatment of acute postoperative pain. Lancet [Internet]. 2011;377(9784):2215–25. Available from: http://dx.doi.org/10.1016/S0140-6736(11)60245-6
6. Dahl JB, Mathiesen O, Kehlet H. An expert opinion on postoperative pain management, with special reference to new developments. Expert Opin Pharmacother. 2010;11(15):2459–70.
7. Gupta A, Kaur K, Sharma S, Goyal S, Arora S, Murthy RSR. Clinical aspects of acute post-operative pain management & its assessment [Internet]. Vol. 1, Journal of Advanced Pharmaceutical Technology and Research. Wolters Kluwer -- Medknow Publications; 2010 [cited 2020 Nov 24]. p. 97–108. Available from: /pmc/articles/PMC3255434/?report=abstract
8. C E, TD J, D K, VG L, B S, R H, et al. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews (Review). 2017;
9. Karlsen APH, Wetterslev M, Hansen SE, Hansen MS, Mathiesen O, Dahl JB. Postoperative pain treatment after total knee arthroplasty: A systematic review. Vol. 12, PLoS ONE. 2017. 1–53 p.
10. Moore RA, Derry S, Aldington D, Wiffen PJ. Single-dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2014;2014(11).
11. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human Adipose Tissue Is a Source of Multipotent Stem Cells □ D. Mol Biol Cell [Internet]. 2002 [cited 2019 Feb 12];13:4279–95. Available from: www.molbiolcell.org.
12. Nho B, Lee J, Lee J, Ryang Ko K, Joong Lee S, Kim S. Effective control of neuropathic pain by transient expression of hepatocyte growth factor in a mouse chronic constriction injury model. [cited 2018 Sep 6]; Available from: www.fasebj.org
13. Klass M, Gavrikov V, Drury D, Stewart B, Hunter S, Denson DD, et al. Intravenous mononuclear marrow cells reverse neuropathic pain from experimental mononeuropathy. Anesth Analg. 2007;104(4):944–8.
14. Guo W, Wang H, Zou S, Gu M, Watanabe M, Wei F, et al. Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain. Stem Cells [Internet]. 2011 Aug [cited 2019 Feb 22];29(8):1294–303. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21630378
15. Totey S, Pal R, Gopinath C, Rao NM, Banerjee P, Krishnamoorthy V, et al. Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury. 2010 [cited 2019 Mar 21]; Available from: https://ac-els-cdn-com.wwwproxy1.library.unsw.edu.au/S146532491070445X/1-s2.0-S146532491070445X-main.pdf?_tid=3e36bce2-c83b-40b3-a8b7-bf7f258fe0c3&acdnat=1553126070_977d62b073d15f8982219c52b6b768f1
16. Bennett GJ, Xie Y-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man [Internet]. Vol. 33, Pain. 1988 [cited 2019 Feb 22]. Available from: https://ac-els-cdn-com.wwwproxy1.library.unsw.edu.au/0304395988902096/1-s2.0-0304395988902096-main.pdf?_tid=ee55f7de-b043-4116-bd93-bc3d91a881c0&acdnat=1550812109_06680d18ab6d161bcd3776507a7d5eee
17. Mert T, Kurt AH, Altun İ, Celik A, Baran F, Gunay I. Pulsed magnetic field enhances therapeutic efficiency of mesenchymal stem cells in chronic neuropathic pain model. Bioelectromagnetics [Internet]. 2017 May 1 [cited 2019 Feb 22];38(4):255–64. Available from: http://doi.wiley.com/10.1002/bem.22038
18. Waterman RS, Betancourt AM. Treating Chronic Pain with Mesenchymal Stem Cells: A Therapeutic Approach Worthy of Continued Investigation. J Stem Cell Res Ther [Internet]. 2011 Oct 21 [cited 2018 Sep 5];01(S2):1–5. Available from: https://www.omicsonline.org/treating-chronic-pain-with-mesenchymal-stem-cells-a-therapeutic-approach-worthy-of-continued-investigation-2157-7633.S2-001.php?aid=2144
19. Xie F, Yue Y, Guan Y, Wang Y. Stem Cells for the Treatment of Neuropathic Pain [Internet]. [cited 2019 Feb 22]. Available from: http://www.japmnet.com/uploadfile/2017/0121/20170121044012254.full.pdf
20. Musolino PL, Coronel MF, Hökfelt T, Villar MJ. Bone marrow stromal cells induce changes in pain behavior after sciatic nerve constriction. Neurosci Lett [Internet]. 2007 [cited 2019 Mar 21];418:97–101. Available from: https://ac-els-cdn-com.wwwproxy1.library.unsw.edu.au/S0304394007002704/1-s2.0-S0304394007002704-main.pdf?_tid=d01361e3-f128-46f9-b597-5b56722ffb71&acdnat=1553124775_3c056555fc965f3eab07c5b257fab1bf
21. Chen C, Chen F, Yao C, Shu S, Feng J, Hu X, et al. Intrathecal Injection of Human Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorates Neuropathic Pain in Rats. Neurochem Res [Internet]. 2016;41(12):3250–60. Available from: http://dx.doi.org/10.1007/s11064-016-2051-5
22. Urdzíková L, Jendelová P, Rina Glogarová K, Burian M, Hájek M, Syková E. Transplantation of Bone Marrow Stem Cells as well as Mobilization by Granulocyte-Colony Stimulating Factor Promotes Recovery after Spinal Cord Injury in Rats. J Neurotrauma [Internet]. 2006 [cited 2019 Mar 21];23(9). Available from: https://search-proquest-com.wwwproxy1.library.unsw.edu.au/docview/204523852?rfr_id=info%3Axri%2Fsid%3Aprimo
23. Sun Y, Zhang D, Li H, Long R, Sun Q. Intrathecal administration of human bone marrow mesenchymal stem cells genetically modified with human proenkephalin gene decrease nociceptive pain in neuropathic rats. Mol Pain [Internet]. 2017 [cited 2018 Sep 17];13:1744806917701445. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28326940
24. Schäfer S, Berger J V, Deumens R, Goursaud S, Hanisch U-K, Hermans E. Influence of intrathecal delivery of bone marrow-derived mesenchymal stem cells on spinal inflammation and pain hypersensitivity in a rat model of peripheral nerve injury [Internet]. 2014 [cited 2019 Mar 21]. Available from: http://www.jneuroinflammation.com/content/11/1/157
25. Chiang C-Y, Liu S-A, Sheu M-L, Chen F-C, Chen C-J, Su H-L, et al. Feasibility of Human Amniotic Fluid Derived Stem Cells in Alleviation of Neuropathic Pain in Chronic Constrictive Injury Nerve Model. Costigan M, editor. PLoS One [Internet]. 2016 Jul 21 [cited 2019 Feb 22];11(7):e0159482. Available from: https://dx.plos.org/10.1371/journal.pone.0159482
26. Hosseini M, Yousefifard M, Aziznejad H, Nasirinezhad F. The Effect of Bone MarroweDerived Mesenchymal Stem Cell Transplantation on Allodynia and Hyperalgesia in Neuropathic Animals: A Systematic Review with Meta-Analysis. Biol Blood Marrow Transplant [Internet]. 2015 [cited 2019 Feb 22];21:1537–44. Available from: http://dx.doi.org/10.1016/j.bbmt.2015.05.008
27. Gama KB, Santos DS, Evangelista AF, Silva DN, de Alcântara AC, dos Santos RR, et al. Conditioned Medium of Bone Marrow-Derived Mesenchymal Stromal Cells as a Therapeutic Approach to Neuropathic Pain: A Preclinical Evaluation. Stem Cells Int [Internet]. 2018 Jan 30 [cited 2018 Sep 5];2018:1–12. Available from: https://www.hindawi.com/journals/sci/2018/8179013/
28. Maione S, Rossi F, de Novellis V, Galderisi U, Luongo L, Giordano C, et al. Long-Lasting Effects of Human Mesenchymal Stem Cell Systemic Administration on Pain-Like Behaviors, Cellular, and Biomolecular Modifications in Neuropathic Mice. Front Integr Neurosci. 2011;5(December):1–10.
29. Huh Y, Ji R-R, Chen G. Neuroinflammation, Bone Marrow Stem Cells, and Chronic Pain. Front Immunol [Internet]. 2017 Aug 21 [cited 2018 Sep 5];8(August):1014. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2017.01014/full
30. Kishk NA, Gabr H, Hamdy S, Afifi L, Abokresha N, Mahmoud H, et al. Case Control Series of Intrathecal Autologous Bone Marrow Mesenchymal Stem Cell Therapy for Chronic Spinal Cord Injury. [cited 2019 Mar 21]; Available from: http://nnr.sagepub.com
31. Franchi S, Valsecchi AE, Borsani E, Procacci P, Ferrari D, Zaffa C, et al. Intravenous neural stem cells abolish nociceptive hypersensitivity and trigger nerve regeneration in experimental neuropathy. Pain [Internet]. 2012 [cited 2019 Feb 22];153:850–61. Available from: https://ac-els-cdn-com.wwwproxy1.library.unsw.edu.au/S0304395912000097/1-s2.0-S0304395912000097-main.pdf?_tid=27f4fe4b-8e04-4b2e-8eed-fe40beb34421&acdnat=1550808909_a4818b330540db0464d10cf427b47612
32. Wei F, Guo W, Zou S, Ren K, Dubner R. Supraspinal glial-neuronal interactions contribute to descending pain facilitation. J Neurosci [Internet]. 2008 Oct 15 [cited 2019 Mar 21];28(42):10482–95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18923025
33. Parr AM, Tator CH, Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant [Internet]. 2007 [cited 2019 Mar 21];40:609–19. Available from: www.nature.com/bmt
34. Genc D, Zibandeh N, Yildiz Y, Aslan S, Demirtas F, Karaoz E, et al. Effects of Mesenchymal Stromal Cells on the Neuropathic Pain Induced by Chronic Constriction Injury in Rats. J Pain Reli [Internet]. 2017 Sep 25 [cited 2019 Feb 22];06(05):1–7. Available from: https://www.omicsonline.org/open-access/effects-of-mesenchymal-stromal-cells-on-the-neuropathic-pain-induced-by-chronic-constriction-injury-in-rats-2167-0846-1000302.php?aid=93917
35. Borsani E, Franchi S, Rossi A, Panerai AE, Maione S, Rodella LF. stem cell transplantation in neuropathic pain. 2011;1.
36. Klein S, Svendsen CN. Stem cells in the injured spinal cord: Reducing the pain and increasing the gain. Nat Neurosci. 2005;8(3):259–60.
37. Karaoz E, Ayça AE, Ae A, Ayhan S, Ayla AE, Sarıboyacı E, et al. Characterization of mesenchymal stem cells from rat bone marrow: ultrastructural properties, differentiation potential and immunophenotypic markers. [cited 2019 Feb 27]; Available from: https://link-springer-com.wwwproxy1.library.unsw.edu.au/content/pdf/10.1007/s00418-009-0629-6.pdf
38. Chen G, Park C-K, Xie R-G, Ji R-R. Intrathecal bone marrow stromal cells inhibit neuropathic pain via TGF-β secretion. J Clin Invest. 2015;
39. Song CH, Zhang EJ, Ko YK, Lee WH. Intrathecal Administration of Mesenchymal Stem Cells Reduces the Reactive Oxygen Species and Pain Behavior in Neuropathic Rats. Korean J Pain [Internet]. 2014 [cited 2019 Mar 21];27(3). Available from: http://dx.doi.org/10.3344/kjp.2014.27.3.239www.epain.org
40. Brini AT, Amodeo G, Ferreira LM, Milani A, Niada S, Moschetti G, et al. Therapeutic effect of human adipose-derived stem cells and their secretome in experimental diabetic pain. Sci Rep [Internet]. 2017 Dec 29 [cited 2019 Feb 22];7(1):9904. Available from: http://www.nature.com/articles/s41598-017-09487-5
41. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. In: Tissue Engineering. 2001. p. 211–28.
42. Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, et al. International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy. 2015;
43. K.B. G, D.S. S, A.F. E, D.N. S, A.C. DA, R.R. DS, et al. Conditioned Medium of Bone Marrow-Derived Mesenchymal Stromal Cells as a Therapeutic Approach to Neuropathic Pain: A Preclinical Evaluation. Stem Cells Int [Internet]. 2018;2018:8179013. Available from: http://www.hindawi.com/journals/sci/contents/%0Ahttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emexb&NEWS=N&AN=620705485
44. Hofer HR, Tuan RS. Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies. Stem Cell Res Ther [Internet]. 2016 Dec 9 [cited 2017 Nov 8];7(1):131. Available from: http://stemcellres.biomedcentral.com/articles/10.1186/s13287-016-0394-0
45. Shubayev VI, Kato K, Myers RR. Cytokines in pain. Transl Pain Res From Mouse to Man. 2009;187–214.
46. Wangzhou A, Paige C, Neerukonda S V., Naik DK, Kume M, David ET, et al. A ligand-receptor interactome platform for discovery of pain mechanisms and therapeutic targets. Sci Signal. 2021;14(674):1–22.
47. Grace PM, Hutchinson MR, Maier SF, Watkins LR. Pathological pain and the neuroimmune interface. Nat Rev Immunol. 2014;
48. Hutchinson MR, Coats BD, Lewis SS, Zhang Y, Sprunger DB, Rezvani N, et al. Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav Immun. 2008;
49. Zhang J-M, An J. Cytokines, Inflammation, and Pain. Int Anesthesiol Clin. 2007;
50. Nho B, Lee J, Lee J, Ryang Ko K, Joong Lee S, Kim S. Effective control of neuropathic pain by transient expression of hepatocyte growth factor in a mouse chronic constriction injury model. Available from: www.fasebj.org
51. Knight BE, Kozlowski N, Havelin J, King T, Crocker SJ, Young EE, et al. TIMP-1 Attenuates the Development of Inflammatory Pain Through MMP-Dependent and Receptor-Mediated Cell Signaling Mechanisms. Front Mol Neurosci. 2019;12(September):1–16.